We are delighted to share that Klavant has been selected to participate in the prestigious Creative Destruction Lab (CDL) Berlin program. Founded at the Rotman School of Management in Toronto, CDL has grown into a global network of innovation hubs, helping early-stage start-ups bring transformative ideas to life.

Klavant is part of the Health Stream, which supports start-ups working on transformative and disruptive solutions in healthcare. The program focuses on technologies that can revolutionize the way medical conditions are prevented, diagnosed or treated as well as increasing the accessibility and efficiency of healthcare. This aligns closely with our mission to bring meaningful improvements to the healthcare sector.

By joining the CDL program, we will benefit from world-class mentorship, valuable networking opportunities and access to potential investors. We believe this collaboration will significantly boost our growth and innovation capabilities.

Stay connected with us as we share updates on this exciting journey. Learn more about the Creative Destruction Lab at creativedestructionlab.com.

We are excited to announce our press release highlighting a significant milestone.

Klavant GmbH has received a grant award of EUR 1.5 million under the „KMU innovativ Medizintechnik“ R&D funding program of the German Federal Ministry of Education and Research (BMBF), effective October 1, 2023.

For more information, find our press release here. (DE / EN)